# Feasibility and Safety and Evaluation of the Potential Efficacy of Autologous Platelet-rich Plasma in the Treatment of Vascular Venous Ulcers

> **NCT01817218** · PHASE1,PHASE2 · COMPLETED · sponsor: **Basque Health Service** · enrollment: 40 (estimated)

## Conditions studied

- Chronic Ulcer

## Interventions

- **DRUG:** Platelet Rich Plasma
- **DEVICE:** Osakidetza protocol

## Key facts

- **NCT ID:** NCT01817218
- **Lead sponsor:** Basque Health Service
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2015-01
- **Final completion:** 2015-04
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2015-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01817218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01817218, "Feasibility and Safety and Evaluation of the Potential Efficacy of Autologous Platelet-rich Plasma in the Treatment of Vascular Venous Ulcers". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT01817218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*